Hepatitis C Trial, Recruiting (NCT05968573)

Hepatitis C Trial, Recruiting NCT05968573 Sponsor: University of South Florida Condition: Hepatitis C

Printed from Voxsanity (voxsanity.com.au) — NCT05968573 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis C

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You can speak English or Spanish and are able to agree to take part in the study
You have not previously tested positive for HIV or Hepatitis C (based on your medical records and what you report)
You are not currently taking part in another HIV or Hepatitis C research study (such as an HIV prevention or vaccine study)
You have not been tested for HIV or Hepatitis C in the past 12 months (based on your medical records and what you report)

Who may not be able to join:

You are under 18 years old
You are unable to speak English or Spanish
You have tested positive for HIV or Hepatitis C
You are currently enrolled in another HIV or Hepatitis C research study
You have had an HIV or Hepatitis C test within the last 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roland C Merchant, MD, University of South Florida

Phone: (212) 524-9814

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05968573

Sponsor: University of South Florida

Phase: Not Applicable

Status: Recruiting

Condition: Hepatitis C

Trial contact: (212) 524-9814

More information: https://clinicaltrials.gov/study/NCT05968573

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You can speak English or Spanish and are able to agree to take part in the study
You have not previously tested positive for HIV or Hepatitis C (based on your medical records and what you report)
You are not currently taking part in another HIV or Hepatitis C research study (such as an HIV prevention or vaccine study)
You have not been tested for HIV or Hepatitis C in the past 12 months (based on your medical records and what you report)

Who may not be able to join:

You are under 18 years old
You are unable to speak English or Spanish
You have tested positive for HIV or Hepatitis C
You are currently enrolled in another HIV or Hepatitis C research study
You have had an HIV or Hepatitis C test within the last 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of South Florida

Registry

ClinicalTrials.gov

Start date

4 December 2023

Est. completion

1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of patients who accept HIV/HCV testing after watching the video with captions; Number of patients who accept HIV/HCV testing after watching the video without captions; Number of patients who accept HIV/HCV testing after speaking with a health educator

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov